The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

Unfortunately, IBD, as well as treatment, have both steadily increased in the last few years. Specifically, Crohn’s disease affects up to 300 people for every 100,000 in North America. Individuals of ...

The resulting paper, "Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: Post-hoc analysis of the RISK study," appears in Gut.

For many people with Crohn’s disease, reaching remission—when inflammation is no longer detectable—seems like a major victory ...

Vedolizumab treatment within 4 weeks of ileocolonic resection outperformed placebo in preventing postoperative endoscopic recurrence of Crohn’s disease in patients with at least one risk factor ...

A study may explain why some patients with Crohn's disease continue to experience symptoms, even in the absence of inflammation. A study from University of Michigan researchers may provide an ...

MetroCreative Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according ...

Crohn's disease and ulcerative colitis are idiopathic ... patients for whom the natural history of disease and response to treatment are predictable. The most widely held hypothesis on the ...